Morgan Wealth ManagementLos AngelesCalifornia - Los Angeles (Private Wealth)$10M$1.5B$10-50M$5-25MShahram HazanyMerrill Wealth ManagementLos AngelesCalifornia - Los Angeles (Private Wealth)$2M$598M$2-100M$2-50MJosh SailarBlue Zone Wealth AdvisorsLos AngelesCalifornia - Los Angeles (Private Wealth)$5M$718M$20-50M$5-25MReva ShakkottaiRBC Wealth ManagementEl SegundoCalifornia - Los Angeles (Private Wealth)$3M$356M$5-30M$3-10MEric FinglesonUBS Wealth ManagementBeverly HillsCalifornia - Los Angeles (Private Wealth)$2.5M$1.4B$4-10M$2-10MRichard McWhorterSRM Private WealthBeverly HillsCalifornia - Los Angeles (Private Wealth)$5M$1.8B$10-75M$10-100MTiffany YuMerrill Private Wealth ManagementLos AngelesCalifornia - Los Angeles (Private Wealth)$10M$1B$5-30M$2.5-10MScott HarriesUBS Private Wealth ManagementLos AngelesCalifornia - Los Angeles (Private Wealth)$2M$45.8B$2-50M$2M-2BThomas MahoneyUBS Private Wealth ManagementLos AngelesCalifornia - Los Angeles (Private Wealth)$10M$607M$25-100M$10-80MPhilip AmbrosinoMorgan Stanley Wealth ManagementBeverly HillsCalifornia - Los Angeles (Private Wealth)$2.5M$383M$3M-80B$2-5MPatrick CodyMerrill Wealth ManagementCentury CityCalifornia - Los Angeles (Private Wealth)$2M$2.7B$10-30M$5-20MBrian CodyMerrill Wealth ManagementLos AngelesCalifornia - Los Angeles (Private Wealth)$2M$2.7B$10-30M$5-20MDarian CohenRaymond James & AssociatesLos AngelesCalifornia - Los Angeles (Private Wealth)$1M$1.1B$5-30M$3-25MJason BlumbergLido AdvisorsLos AngelesCalifornia - Los Angeles (Private Wealth)$1M$3.4B$2-50M$1.5-50MJames McGarryWells Fargo AdvisorsBeverly HillsCalifornia - Los Angeles (Private Wealth)$1M$1.7B$8-100M$1-500MCraig BenellMorgan Stanley Private Wealth ManagementLos AngelesCalifornia - Los Angeles (Private Wealth)$5M$628M$25-50M$10-100MDan GrayUBS Private Wealth ManagementLos AngelesCalifornia - Los Angeles (Private Wealth)$10M$45.8B$25M-1B$10-50MVinnie DiCarloWells Fargo AdvisorsEl SegundoCalifornia - Los Angeles (Private Wealth)$10M$1.7B$25-100M$20-40MJonathan SheffieldMerrill Wealth ManagementLos AngelesCalifornia - Los Angeles (Private Wealth)$1M$1.4B$5-330M$20-270MProfile SpotlightBruce BeerbowerJ.P
"Patients receiving inadequate follow-up care experience higher rates of medication discontinuation and more adverse effects compared with those receiving regular follow-up." Obesity, 2025 Improper Titration Turns Side Effects into Dealbreakers Semaglutide requires gradual dose increases to allow your body to adjust
The table lists 10 to 15 percent of body weight for semaglutide and 15 to 22 percent for tirzepatide in 12-month trials
Clinical symptoms include impaired consciousness, seizures, autism spectrum disorder and depression, as well as extrapyramidal and pyramidal fasciculus symptoms
At SCVC we developed a 12 month tracker booklet called N-of-1 that anyone can purchase on Amazon or via the Cardiometabolic toolkit Optional Add-Ons AI dietitian support (every 2 weeks via app or platform) CarbR Test for those without access to CGMs Time-restricted eating coaching GLP-1 mimetics if VAT remains high after 6 months of structured lifestyle change Summary Table: Non-Medication VAT Reduction Final Message You can reduce visceral fat without medication but it requires consistency, insight, and personalised feedback
Oral tirzepatide and semaglutide delay stomach emptying, increasing aspiration risk during anesthesia
